nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—Epirubicin—sarcoma	0.136	0.519	CrCtD
Daunorubicin—Doxorubicin—sarcoma	0.126	0.481	CrCtD
Daunorubicin—Anthracyclines—Epirubicin—sarcoma	0.0748	0.215	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Mitoxantrone—sarcoma	0.0724	0.208	CiPCiCtD
Daunorubicin—Anthracyclines—Doxorubicin—sarcoma	0.0692	0.199	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Etoposide—sarcoma	0.0568	0.163	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Epirubicin—sarcoma	0.0391	0.112	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Doxorubicin—sarcoma	0.0362	0.104	CiPCiCtD
Daunorubicin—Idarubicin—Epirubicin—sarcoma	0.029	0.173	CrCrCtD
Daunorubicin—Valrubicin—Epirubicin—sarcoma	0.029	0.173	CrCrCtD
Daunorubicin—Doxorubicin—Epirubicin—sarcoma	0.029	0.173	CrCrCtD
Daunorubicin—Idarubicin—Doxorubicin—sarcoma	0.0268	0.16	CrCrCtD
Daunorubicin—Valrubicin—Doxorubicin—sarcoma	0.0268	0.16	CrCrCtD
Daunorubicin—Epirubicin—Doxorubicin—sarcoma	0.0268	0.16	CrCrCtD
Daunorubicin—YWHAG—Epirubicin—sarcoma	0.024	0.139	CbGbCtD
Daunorubicin—TOP2B—Etoposide—sarcoma	0.0187	0.108	CbGbCtD
Daunorubicin—YWHAG—Doxorubicin—sarcoma	0.0127	0.0737	CbGbCtD
Daunorubicin—ABCC6—Dactinomycin—sarcoma	0.0126	0.0731	CbGbCtD
Daunorubicin—ABCC6—Etoposide—sarcoma	0.00713	0.0413	CbGbCtD
Daunorubicin—TOP2A—Mitoxantrone—sarcoma	0.00602	0.0348	CbGbCtD
Daunorubicin—ABCC10—Vincristine—sarcoma	0.00595	0.0344	CbGbCtD
Daunorubicin—ABCC10—Etoposide—sarcoma	0.00545	0.0315	CbGbCtD
Daunorubicin—POR—Doxorubicin—sarcoma	0.00529	0.0306	CbGbCtD
Daunorubicin—TOP2A—Epirubicin—sarcoma	0.00487	0.0282	CbGbCtD
Daunorubicin—ABCC6—Doxorubicin—sarcoma	0.00487	0.0281	CbGbCtD
Daunorubicin—CYP1B1—Mitoxantrone—sarcoma	0.0047	0.0272	CbGbCtD
Daunorubicin—TOP2A—Etoposide—sarcoma	0.0038	0.022	CbGbCtD
Daunorubicin—ABCC1—Dactinomycin—sarcoma	0.00373	0.0216	CbGbCtD
Daunorubicin—ABCC10—Doxorubicin—sarcoma	0.00372	0.0215	CbGbCtD
Daunorubicin—ABCC1—Mitoxantrone—sarcoma	0.00334	0.0193	CbGbCtD
Daunorubicin—ABCB11—Vincristine—sarcoma	0.00323	0.0187	CbGbCtD
Daunorubicin—XDH—Doxorubicin—sarcoma	0.00304	0.0176	CbGbCtD
Daunorubicin—ABCC1—Epirubicin—sarcoma	0.0027	0.0156	CbGbCtD
Daunorubicin—CYP1A1—Dacarbazine—sarcoma	0.00266	0.0154	CbGbCtD
Daunorubicin—TOP2A—Doxorubicin—sarcoma	0.00259	0.015	CbGbCtD
Daunorubicin—ABCG2—Dactinomycin—sarcoma	0.0025	0.0144	CbGbCtD
Daunorubicin—ABCC1—Vincristine—sarcoma	0.0023	0.0133	CbGbCtD
Daunorubicin—ABCG2—Mitoxantrone—sarcoma	0.00223	0.0129	CbGbCtD
Daunorubicin—ABCC1—Etoposide—sarcoma	0.0021	0.0122	CbGbCtD
Daunorubicin—CYP1B1—Doxorubicin—sarcoma	0.00202	0.0117	CbGbCtD
Daunorubicin—ABCB11—Doxorubicin—sarcoma	0.00202	0.0117	CbGbCtD
Daunorubicin—ABCC2—Vincristine—sarcoma	0.0017	0.00983	CbGbCtD
Daunorubicin—ABCC2—Etoposide—sarcoma	0.00156	0.00901	CbGbCtD
Daunorubicin—ABCG2—Vincristine—sarcoma	0.00154	0.00889	CbGbCtD
Daunorubicin—ABCC1—Doxorubicin—sarcoma	0.00144	0.0083	CbGbCtD
Daunorubicin—ABCG2—Etoposide—sarcoma	0.00141	0.00814	CbGbCtD
Daunorubicin—ABCC6—dermis—sarcoma	0.0012	0.109	CbGeAlD
Daunorubicin—CYP1A2—Dacarbazine—sarcoma	0.00119	0.00686	CbGbCtD
Daunorubicin—CYP3A4—Thiotepa—sarcoma	0.00112	0.00649	CbGbCtD
Daunorubicin—ABCC2—Doxorubicin—sarcoma	0.00106	0.00614	CbGbCtD
Daunorubicin—ABCG2—Doxorubicin—sarcoma	0.00096	0.00555	CbGbCtD
Daunorubicin—ABCB1—Dactinomycin—sarcoma	0.0009	0.0052	CbGbCtD
Daunorubicin—CYP3A5—Vincristine—sarcoma	0.000851	0.00492	CbGbCtD
Daunorubicin—ABCB1—Mitoxantrone—sarcoma	0.000805	0.00466	CbGbCtD
Daunorubicin—CYP3A5—Etoposide—sarcoma	0.00078	0.00451	CbGbCtD
Daunorubicin—CYP1A2—Etoposide—sarcoma	0.000581	0.00336	CbGbCtD
Daunorubicin—ABCB1—Vincristine—sarcoma	0.000554	0.0032	CbGbCtD
Daunorubicin—ABCB1—Etoposide—sarcoma	0.000508	0.00294	CbGbCtD
Daunorubicin—CYP3A4—Mitoxantrone—sarcoma	0.000482	0.00279	CbGbCtD
Daunorubicin—ABCB1—Doxorubicin—sarcoma	0.000346	0.002	CbGbCtD
Daunorubicin—CYP3A4—Vincristine—sarcoma	0.000332	0.00192	CbGbCtD
Daunorubicin—CYP3A4—Etoposide—sarcoma	0.000304	0.00176	CbGbCtD
Daunorubicin—YWHAG—mammary gland—sarcoma	0.000278	0.0254	CbGeAlD
Daunorubicin—TOP2B—mammary gland—sarcoma	0.000268	0.0244	CbGeAlD
Daunorubicin—NR5A1—hematopoietic system—sarcoma	0.000257	0.0234	CbGeAlD
Daunorubicin—TOP2B—Teniposide—Etoposide—sarcoma	0.000236	0.326	CbGdCrCtD
Daunorubicin—ABCC6—Podofilox—Etoposide—sarcoma	0.00021	0.291	CbGdCrCtD
Daunorubicin—CYP3A4—Doxorubicin—sarcoma	0.000207	0.0012	CbGbCtD
Daunorubicin—YWHAG—myometrium—sarcoma	0.000198	0.018	CbGeAlD
Daunorubicin—TOP2B—myometrium—sarcoma	0.00019	0.0173	CbGeAlD
Daunorubicin—TOP2B—embryo—sarcoma	0.000183	0.0167	CbGeAlD
Daunorubicin—NR5A1—lymphoid tissue—sarcoma	0.000181	0.0165	CbGeAlD
Daunorubicin—ABCC6—hematopoietic system—sarcoma	0.00018	0.0164	CbGeAlD
Daunorubicin—YWHAG—seminal vesicle—sarcoma	0.000178	0.0163	CbGeAlD
Daunorubicin—ABCC6—connective tissue—sarcoma	0.000173	0.0158	CbGeAlD
Daunorubicin—TOP2B—seminal vesicle—sarcoma	0.000172	0.0157	CbGeAlD
Daunorubicin—YWHAG—hematopoietic system—sarcoma	0.00017	0.0155	CbGeAlD
Daunorubicin—TOP2B—hematopoietic system—sarcoma	0.000163	0.0149	CbGeAlD
Daunorubicin—YWHAG—connective tissue—sarcoma	0.000163	0.0149	CbGeAlD
Daunorubicin—TOP2B—connective tissue—sarcoma	0.000157	0.0143	CbGeAlD
Daunorubicin—POR—myometrium—sarcoma	0.00015	0.0137	CbGeAlD
Daunorubicin—YWHAG—smooth muscle tissue—sarcoma	0.000149	0.0136	CbGeAlD
Daunorubicin—TOP2B—smooth muscle tissue—sarcoma	0.000144	0.0131	CbGeAlD
Daunorubicin—NR5A1—testis—sarcoma	0.000141	0.0128	CbGeAlD
Daunorubicin—TOP2A—myometrium—sarcoma	0.00014	0.0128	CbGeAlD
Daunorubicin—POR—seminal vesicle—sarcoma	0.000136	0.0124	CbGeAlD
Daunorubicin—CYP1B1—mammary gland—sarcoma	0.000132	0.012	CbGeAlD
Daunorubicin—YWHAG—cardiac atrium—sarcoma	0.000129	0.0117	CbGeAlD
Daunorubicin—YWHAG—uterus—sarcoma	0.000128	0.0117	CbGeAlD
Daunorubicin—TOP2B—cardiac atrium—sarcoma	0.000124	0.0113	CbGeAlD
Daunorubicin—TOP2B—uterus—sarcoma	0.000123	0.0112	CbGeAlD
Daunorubicin—YWHAG—lymphoid tissue—sarcoma	0.000119	0.0109	CbGeAlD
Daunorubicin—ABCC10—myometrium—sarcoma	0.000119	0.0109	CbGeAlD
Daunorubicin—TOP2B—lymphoid tissue—sarcoma	0.000115	0.0105	CbGeAlD
Daunorubicin—YWHAG—tendon—sarcoma	0.000112	0.0102	CbGeAlD
Daunorubicin—YWHAG—bone marrow—sarcoma	0.000109	0.00991	CbGeAlD
Daunorubicin—TOP2B—tendon—sarcoma	0.000108	0.00986	CbGeAlD
Daunorubicin—ABCC10—seminal vesicle—sarcoma	0.000108	0.00981	CbGeAlD
Daunorubicin—TOP2B—bone marrow—sarcoma	0.000105	0.00955	CbGeAlD
Daunorubicin—ABCC10—hematopoietic system—sarcoma	0.000102	0.00932	CbGeAlD
Daunorubicin—POR—cardiac atrium—sarcoma	9.79e-05	0.00892	CbGeAlD
Daunorubicin—ABCC6—liver—sarcoma	9.33e-05	0.0085	CbGeAlD
Daunorubicin—YWHAG—testis—sarcoma	9.29e-05	0.00847	CbGeAlD
Daunorubicin—TOP2A—uterus—sarcoma	9.08e-05	0.00827	CbGeAlD
Daunorubicin—TOP2B—testis—sarcoma	8.96e-05	0.00816	CbGeAlD
Daunorubicin—ABCB11—testis—sarcoma	8.85e-05	0.00807	CbGeAlD
Daunorubicin—YWHAG—liver—sarcoma	8.79e-05	0.00801	CbGeAlD
Daunorubicin—XDH—liver—sarcoma	8.57e-05	0.00781	CbGeAlD
Daunorubicin—POR—tendon—sarcoma	8.53e-05	0.00778	CbGeAlD
Daunorubicin—TOP2B—liver—sarcoma	8.47e-05	0.00772	CbGeAlD
Daunorubicin—ABCC1—myometrium—sarcoma	8.43e-05	0.00768	CbGeAlD
Daunorubicin—ABCB11—liver—sarcoma	8.37e-05	0.00763	CbGeAlD
Daunorubicin—POR—bone marrow—sarcoma	8.27e-05	0.00753	CbGeAlD
Daunorubicin—CYP1B1—hematopoietic system—sarcoma	8.05e-05	0.00733	CbGeAlD
Daunorubicin—TOP2A—tendon—sarcoma	7.95e-05	0.00725	CbGeAlD
Daunorubicin—ABCC10—cardiac atrium—sarcoma	7.77e-05	0.00708	CbGeAlD
Daunorubicin—CYP1B1—connective tissue—sarcoma	7.75e-05	0.00706	CbGeAlD
Daunorubicin—ABCC10—uterus—sarcoma	7.73e-05	0.00704	CbGeAlD
Daunorubicin—TOP2A—bone marrow—sarcoma	7.7e-05	0.00702	CbGeAlD
Daunorubicin—ABCC1—seminal vesicle—sarcoma	7.61e-05	0.00694	CbGeAlD
Daunorubicin—ABCC10—lymphoid tissue—sarcoma	7.2e-05	0.00656	CbGeAlD
Daunorubicin—CYP1B1—smooth muscle tissue—sarcoma	7.09e-05	0.00646	CbGeAlD
Daunorubicin—POR—testis—sarcoma	7.07e-05	0.00644	CbGeAlD
Daunorubicin—CYP1B1—skin of body—sarcoma	7e-05	0.00637	CbGeAlD
Daunorubicin—ABCG2—myometrium—sarcoma	6.98e-05	0.00636	CbGeAlD
Daunorubicin—ABCC10—tendon—sarcoma	6.77e-05	0.00617	CbGeAlD
Daunorubicin—YWHAG—lymph node—sarcoma	6.74e-05	0.00614	CbGeAlD
Daunorubicin—POR—liver—sarcoma	6.68e-05	0.00609	CbGeAlD
Daunorubicin—TOP2A—testis—sarcoma	6.59e-05	0.006	CbGeAlD
Daunorubicin—ABCC10—bone marrow—sarcoma	6.56e-05	0.00598	CbGeAlD
Daunorubicin—TOP2B—lymph node—sarcoma	6.49e-05	0.00592	CbGeAlD
Daunorubicin—ABCG2—seminal vesicle—sarcoma	6.3e-05	0.00574	CbGeAlD
Daunorubicin—CYP1B1—uterus—sarcoma	6.08e-05	0.00554	CbGeAlD
Daunorubicin—TOP2A—Vindesine—Vincristine—sarcoma	6.04e-05	0.0835	CbGdCrCtD
Daunorubicin—CYP1A2—hematopoietic system—sarcoma	5.77e-05	0.00525	CbGeAlD
Daunorubicin—CYP1A1—hematopoietic system—sarcoma	5.69e-05	0.00518	CbGeAlD
Daunorubicin—CYP1B1—lymphoid tissue—sarcoma	5.66e-05	0.00516	CbGeAlD
Daunorubicin—ABCC10—testis—sarcoma	5.61e-05	0.00511	CbGeAlD
Daunorubicin—CYP3A5—hematopoietic system—sarcoma	5.56e-05	0.00507	CbGeAlD
Daunorubicin—ABCC1—cardiac atrium—sarcoma	5.5e-05	0.00501	CbGeAlD
Daunorubicin—ABCC1—uterus—sarcoma	5.47e-05	0.00498	CbGeAlD
Daunorubicin—ABCC2—tendon—sarcoma	5.44e-05	0.00495	CbGeAlD
Daunorubicin—CYP1B1—tendon—sarcoma	5.32e-05	0.00485	CbGeAlD
Daunorubicin—ABCC10—liver—sarcoma	5.3e-05	0.00483	CbGeAlD
Daunorubicin—POR—lymph node—sarcoma	5.12e-05	0.00467	CbGeAlD
Daunorubicin—CYP1A1—skin of body—sarcoma	4.95e-05	0.00451	CbGeAlD
Daunorubicin—ABCG2—HIF-1-alpha transcription factor network—NPM1—sarcoma	4.86e-05	0.00574	CbGpPWpGaD
Daunorubicin—ABCC1—tendon—sarcoma	4.79e-05	0.00436	CbGeAlD
Daunorubicin—TOP2A—lymph node—sarcoma	4.77e-05	0.00435	CbGeAlD
Daunorubicin—YWHAG—Class I PI3K signaling events mediated by Akt—SRC—sarcoma	4.63e-05	0.00546	CbGpPWpGaD
Daunorubicin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	4.62e-05	0.00545	CbGpPWpGaD
Daunorubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—SRC—sarcoma	4.53e-05	0.00534	CbGpPWpGaD
Daunorubicin—ABCG2—uterus—sarcoma	4.53e-05	0.00412	CbGeAlD
Daunorubicin—ABCC2—testis—sarcoma	4.5e-05	0.0041	CbGeAlD
Daunorubicin—YWHAG—Activation of BH3-only proteins—TP53—sarcoma	4.46e-05	0.00526	CbGpPWpGaD
Daunorubicin—CYP1B1—testis—sarcoma	4.41e-05	0.00402	CbGeAlD
Daunorubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—NRAS—sarcoma	4.35e-05	0.00514	CbGpPWpGaD
Daunorubicin—CYP1A1—cardiac atrium—sarcoma	4.32e-05	0.00393	CbGeAlD
Daunorubicin—CYP1A1—uterus—sarcoma	4.3e-05	0.00391	CbGeAlD
Daunorubicin—ABCC2—liver—sarcoma	4.26e-05	0.00388	CbGeAlD
Daunorubicin—NR5A1—Developmental Biology—MYOD1—sarcoma	4.24e-05	0.00501	CbGpPWpGaD
Daunorubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—PLCG1—sarcoma	4.24e-05	0.005	CbGpPWpGaD
Daunorubicin—CYP3A4—hematopoietic system—sarcoma	4.17e-05	0.0038	CbGeAlD
Daunorubicin—CYP1B1—liver—sarcoma	4.17e-05	0.0038	CbGeAlD
Daunorubicin—ABCC10—lymph node—sarcoma	4.06e-05	0.0037	CbGeAlD
Daunorubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—ATF1—sarcoma	4.03e-05	0.00475	CbGpPWpGaD
Daunorubicin—ABCC1—testis—sarcoma	3.97e-05	0.00361	CbGeAlD
Daunorubicin—TOP2A—Gastric Cancer Network 2—CTNNB1—sarcoma	3.95e-05	0.00466	CbGpPWpGaD
Daunorubicin—YWHAG—FoxO family signaling—CTNNB1—sarcoma	3.91e-05	0.00462	CbGpPWpGaD
Daunorubicin—ABCG2—bone marrow—sarcoma	3.84e-05	0.0035	CbGeAlD
Daunorubicin—TOP2A—Vinorelbine—Vincristine—sarcoma	3.81e-05	0.0527	CbGdCrCtD
Daunorubicin—TOP2A—Podofilox—Etoposide—sarcoma	3.81e-05	0.0527	CbGdCrCtD
Daunorubicin—TOP2A—Teniposide—Etoposide—sarcoma	3.81e-05	0.0527	CbGdCrCtD
Daunorubicin—ABCC1—liver—sarcoma	3.75e-05	0.00342	CbGeAlD
Daunorubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—KRAS—sarcoma	3.75e-05	0.00442	CbGpPWpGaD
Daunorubicin—ABCG2—HIF-2-alpha transcription factor network—KDR—sarcoma	3.57e-05	0.00421	CbGpPWpGaD
Daunorubicin—YWHAG—PDGFR-beta signaling pathway—PDGFRB—sarcoma	3.57e-05	0.00421	CbGpPWpGaD
Daunorubicin—ABCC1—S1P1 pathway—VEGFA—sarcoma	3.56e-05	0.0042	CbGpPWpGaD
Daunorubicin—YWHAG—LKB1 signaling events—MYC—sarcoma	3.52e-05	0.00415	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—FUS—sarcoma	3.51e-05	0.00415	CbGpPWpGaD
Daunorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—sarcoma	3.45e-05	0.00407	CbGpPWpGaD
Daunorubicin—ABCB1—myometrium—sarcoma	3.44e-05	0.00313	CbGeAlD
Daunorubicin—ABCG2—HIF-1-alpha transcription factor network—CXCR4—sarcoma	3.44e-05	0.00405	CbGpPWpGaD
Daunorubicin—YWHAG—a6b1 and a6b4 Integrin signaling—EGFR—sarcoma	3.32e-05	0.00392	CbGpPWpGaD
Daunorubicin—CYP1A1—Melatonin metabolism and effects—FOXO1—sarcoma	3.32e-05	0.00391	CbGpPWpGaD
Daunorubicin—ABCB1—embryo—sarcoma	3.31e-05	0.00302	CbGeAlD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	3.3e-05	0.00389	CbGpPWpGaD
Daunorubicin—CYP1A1—Estrogen Receptor Pathway—JUN—sarcoma	3.29e-05	0.00388	CbGpPWpGaD
Daunorubicin—ABCG2—testis—sarcoma	3.28e-05	0.00299	CbGeAlD
Daunorubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—sarcoma	3.28e-05	0.00387	CbGpPWpGaD
Daunorubicin—ABCC2—lymph node—sarcoma	3.26e-05	0.00297	CbGeAlD
Daunorubicin—CYP3A5—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	3.24e-05	0.00383	CbGpPWpGaD
Daunorubicin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	3.21e-05	0.00379	CbGpPWpGaD
Daunorubicin—TOP2A—Gastric Cancer Network 2—MYC—sarcoma	3.2e-05	0.00377	CbGpPWpGaD
Daunorubicin—CYP1B1—lymph node—sarcoma	3.2e-05	0.00291	CbGeAlD
Daunorubicin—YWHAG—Intrinsic Pathway for Apoptosis—TP53—sarcoma	3.19e-05	0.00376	CbGpPWpGaD
Daunorubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—HRAS—sarcoma	3.19e-05	0.00376	CbGpPWpGaD
Daunorubicin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	3.16e-05	0.00373	CbGpPWpGaD
Daunorubicin—TOP2A—Gastric Cancer Network 2—EGFR—sarcoma	3.13e-05	0.00369	CbGpPWpGaD
Daunorubicin—ABCB1—seminal vesicle—sarcoma	3.11e-05	0.00283	CbGeAlD
Daunorubicin—ABCG2—liver—sarcoma	3.1e-05	0.00283	CbGeAlD
Daunorubicin—NR5A1—Developmental Biology—PTPRC—sarcoma	3.07e-05	0.00362	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—PLCG1—sarcoma	3e-05	0.00354	CbGpPWpGaD
Daunorubicin—CYP1A2—liver—sarcoma	2.99e-05	0.00272	CbGeAlD
Daunorubicin—YWHAG—ErbB1 downstream signaling—CREB1—sarcoma	2.98e-05	0.00352	CbGpPWpGaD
Daunorubicin—ABCB1—hematopoietic system—sarcoma	2.95e-05	0.00269	CbGeAlD
Daunorubicin—CYP1A1—liver—sarcoma	2.95e-05	0.00268	CbGeAlD
Daunorubicin—YWHAG—LKB1 signaling events—TP53—sarcoma	2.89e-05	0.00341	CbGpPWpGaD
Daunorubicin—CYP3A5—liver—sarcoma	2.88e-05	0.00263	CbGeAlD
Daunorubicin—ABCC1—lymph node—sarcoma	2.87e-05	0.00262	CbGeAlD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—STAG1—sarcoma	2.75e-05	0.00325	CbGpPWpGaD
Daunorubicin—YWHAG—mTOR signaling pathway—NRAS—sarcoma	2.68e-05	0.00316	CbGpPWpGaD
Daunorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—sarcoma	2.67e-05	0.00315	CbGpPWpGaD
Daunorubicin—YWHAG—a6b1 and a6b4 Integrin signaling—HRAS—sarcoma	2.66e-05	0.00314	CbGpPWpGaD
Daunorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—sarcoma	2.66e-05	0.00314	CbGpPWpGaD
Daunorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—sarcoma	2.64e-05	0.00312	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—NPM1—sarcoma	2.63e-05	0.0031	CbGpPWpGaD
Daunorubicin—TOP2A—Gastric Cancer Network 2—TP53—sarcoma	2.63e-05	0.0031	CbGpPWpGaD
Daunorubicin—TOP2A—Vinblastine—Vincristine—sarcoma	2.62e-05	0.0362	CbGdCrCtD
Daunorubicin—Renal impairment—Doxorubicin—sarcoma	2.55e-05	0.000862	CcSEcCtD
Daunorubicin—Urticaria—Thiotepa—sarcoma	2.54e-05	0.00086	CcSEcCtD
Daunorubicin—Malaise—Etoposide—sarcoma	2.54e-05	0.000859	CcSEcCtD
Daunorubicin—Abdominal pain—Thiotepa—sarcoma	2.53e-05	0.000855	CcSEcCtD
Daunorubicin—Body temperature increased—Thiotepa—sarcoma	2.53e-05	0.000855	CcSEcCtD
Daunorubicin—YWHAG—Cell Cycle—MDM2—sarcoma	2.52e-05	0.00298	CbGpPWpGaD
Daunorubicin—Leukopenia—Etoposide—sarcoma	2.52e-05	0.000852	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	2.52e-05	0.000851	CcSEcCtD
Daunorubicin—Abdominal pain—Dactinomycin—sarcoma	2.51e-05	0.000849	CcSEcCtD
Daunorubicin—Body temperature increased—Dactinomycin—sarcoma	2.51e-05	0.000849	CcSEcCtD
Daunorubicin—Anaphylactoid reaction—Doxorubicin—sarcoma	2.51e-05	0.000847	CcSEcCtD
Daunorubicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	2.5e-05	0.00295	CbGpPWpGaD
Daunorubicin—Cardiac arrest—Epirubicin—sarcoma	2.49e-05	0.000843	CcSEcCtD
Daunorubicin—Cardiac failure—Doxorubicin—sarcoma	2.49e-05	0.00084	CcSEcCtD
Daunorubicin—Mood swings—Epirubicin—sarcoma	2.48e-05	0.00084	CcSEcCtD
Daunorubicin—Loss of consciousness—Etoposide—sarcoma	2.48e-05	0.000837	CcSEcCtD
Daunorubicin—Decreased appetite—Vincristine—sarcoma	2.47e-05	0.000834	CcSEcCtD
Daunorubicin—Ataxia—Epirubicin—sarcoma	2.47e-05	0.000834	CcSEcCtD
Daunorubicin—Dyspnoea—Mitoxantrone—sarcoma	2.46e-05	0.000833	CcSEcCtD
Daunorubicin—YWHAG—Cell Cycle—STAG1—sarcoma	2.46e-05	0.00291	CbGpPWpGaD
Daunorubicin—Cough—Etoposide—sarcoma	2.46e-05	0.000831	CcSEcCtD
Daunorubicin—Somnolence—Mitoxantrone—sarcoma	2.46e-05	0.000831	CcSEcCtD
Daunorubicin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	2.45e-05	0.00289	CbGpPWpGaD
Daunorubicin—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	2.45e-05	0.00289	CbGpPWpGaD
Daunorubicin—Fatigue—Vincristine—sarcoma	2.45e-05	0.000827	CcSEcCtD
Daunorubicin—Convulsion—Etoposide—sarcoma	2.44e-05	0.000825	CcSEcCtD
Daunorubicin—Dehydration—Epirubicin—sarcoma	2.44e-05	0.000824	CcSEcCtD
Daunorubicin—Hypertension—Etoposide—sarcoma	2.43e-05	0.000822	CcSEcCtD
Daunorubicin—Pain—Vincristine—sarcoma	2.43e-05	0.000821	CcSEcCtD
Daunorubicin—Constipation—Vincristine—sarcoma	2.43e-05	0.000821	CcSEcCtD
Daunorubicin—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	2.43e-05	0.00082	CcSEcCtD
Daunorubicin—Dry skin—Epirubicin—sarcoma	2.4e-05	0.000813	CcSEcCtD
Daunorubicin—Decreased appetite—Mitoxantrone—sarcoma	2.4e-05	0.000812	CcSEcCtD
Daunorubicin—Chest pain—Etoposide—sarcoma	2.4e-05	0.000811	CcSEcCtD
Daunorubicin—Affect lability—Doxorubicin—sarcoma	2.39e-05	0.000807	CcSEcCtD
Daunorubicin—Fatigue—Mitoxantrone—sarcoma	2.38e-05	0.000806	CcSEcCtD
Daunorubicin—ABCG2—lymph node—sarcoma	2.38e-05	0.00217	CbGeAlD
Daunorubicin—Discomfort—Etoposide—sarcoma	2.37e-05	0.000801	CcSEcCtD
Daunorubicin—Pain—Mitoxantrone—sarcoma	2.36e-05	0.000799	CcSEcCtD
Daunorubicin—Constipation—Mitoxantrone—sarcoma	2.36e-05	0.000799	CcSEcCtD
Daunorubicin—Hypersensitivity—Thiotepa—sarcoma	2.36e-05	0.000797	CcSEcCtD
Daunorubicin—Hypersensitivity—Dactinomycin—sarcoma	2.34e-05	0.000791	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Vincristine—sarcoma	2.32e-05	0.000785	CcSEcCtD
Daunorubicin—Gastritis—Epirubicin—sarcoma	2.32e-05	0.000785	CcSEcCtD
Daunorubicin—Confusional state—Etoposide—sarcoma	2.32e-05	0.000784	CcSEcCtD
Daunorubicin—YWHAG—mTOR signaling pathway—KRAS—sarcoma	2.31e-05	0.00272	CbGpPWpGaD
Daunorubicin—Cardiac arrest—Doxorubicin—sarcoma	2.31e-05	0.00078	CcSEcCtD
Daunorubicin—Anaphylactic shock—Etoposide—sarcoma	2.3e-05	0.000777	CcSEcCtD
Daunorubicin—Mood swings—Doxorubicin—sarcoma	2.3e-05	0.000777	CcSEcCtD
Daunorubicin—Asthenia—Thiotepa—sarcoma	2.3e-05	0.000776	CcSEcCtD
Daunorubicin—Infection—Etoposide—sarcoma	2.28e-05	0.000772	CcSEcCtD
Daunorubicin—Ataxia—Doxorubicin—sarcoma	2.28e-05	0.000771	CcSEcCtD
Daunorubicin—Asthenia—Dactinomycin—sarcoma	2.28e-05	0.000771	CcSEcCtD
Daunorubicin—Feeling abnormal—Mitoxantrone—sarcoma	2.28e-05	0.00077	CcSEcCtD
Daunorubicin—Dysphagia—Epirubicin—sarcoma	2.27e-05	0.000766	CcSEcCtD
Daunorubicin—Pruritus—Thiotepa—sarcoma	2.26e-05	0.000766	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Mitoxantrone—sarcoma	2.26e-05	0.000764	CcSEcCtD
Daunorubicin—CYP1A1—lymph node—sarcoma	2.26e-05	0.00206	CbGeAlD
Daunorubicin—Dehydration—Doxorubicin—sarcoma	2.26e-05	0.000763	CcSEcCtD
Daunorubicin—Thrombocytopenia—Etoposide—sarcoma	2.25e-05	0.000761	CcSEcCtD
Daunorubicin—Tachycardia—Etoposide—sarcoma	2.24e-05	0.000759	CcSEcCtD
Daunorubicin—Abdominal pain—Vincristine—sarcoma	2.24e-05	0.000759	CcSEcCtD
Daunorubicin—Body temperature increased—Vincristine—sarcoma	2.24e-05	0.000759	CcSEcCtD
Daunorubicin—CYP1B1—Tryptophan metabolism—MDM2—sarcoma	2.23e-05	0.00264	CbGpPWpGaD
Daunorubicin—ABCB1—uterus—sarcoma	2.23e-05	0.00203	CbGeAlD
Daunorubicin—Dry skin—Doxorubicin—sarcoma	2.22e-05	0.000752	CcSEcCtD
Daunorubicin—Hyperhidrosis—Etoposide—sarcoma	2.22e-05	0.000751	CcSEcCtD
Daunorubicin—Angina pectoris—Epirubicin—sarcoma	2.21e-05	0.000746	CcSEcCtD
Daunorubicin—Urticaria—Mitoxantrone—sarcoma	2.2e-05	0.000742	CcSEcCtD
Daunorubicin—Anorexia—Etoposide—sarcoma	2.19e-05	0.000741	CcSEcCtD
Daunorubicin—Diarrhoea—Thiotepa—sarcoma	2.19e-05	0.00074	CcSEcCtD
Daunorubicin—Body temperature increased—Mitoxantrone—sarcoma	2.18e-05	0.000739	CcSEcCtD
Daunorubicin—Abdominal pain—Mitoxantrone—sarcoma	2.18e-05	0.000739	CcSEcCtD
Daunorubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—CREB1—sarcoma	2.18e-05	0.00257	CbGpPWpGaD
Daunorubicin—Diarrhoea—Dactinomycin—sarcoma	2.17e-05	0.000735	CcSEcCtD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—CREB1—sarcoma	2.17e-05	0.00256	CbGpPWpGaD
Daunorubicin—CYP3A4—liver—sarcoma	2.16e-05	0.00197	CbGeAlD
Daunorubicin—Pancytopenia—Epirubicin—sarcoma	2.15e-05	0.000728	CcSEcCtD
Daunorubicin—Gastritis—Doxorubicin—sarcoma	2.15e-05	0.000726	CcSEcCtD
Daunorubicin—YWHAG—ErbB1 downstream signaling—JUN—sarcoma	2.14e-05	0.00253	CbGpPWpGaD
Daunorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—sarcoma	2.14e-05	0.00253	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—FOXO1—sarcoma	2.13e-05	0.00251	CbGpPWpGaD
Daunorubicin—Neutropenia—Epirubicin—sarcoma	2.12e-05	0.000716	CcSEcCtD
Daunorubicin—Dysuria—Epirubicin—sarcoma	2.12e-05	0.000716	CcSEcCtD
Daunorubicin—Dizziness—Thiotepa—sarcoma	2.12e-05	0.000716	CcSEcCtD
Daunorubicin—CYP1A2—Melatonin metabolism and effects—FOXO1—sarcoma	2.11e-05	0.00249	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—NPM1—sarcoma	2.11e-05	0.00249	CbGpPWpGaD
Daunorubicin—Dysphagia—Doxorubicin—sarcoma	2.1e-05	0.000709	CcSEcCtD
Daunorubicin—CYP1A2—Estrogen Receptor Pathway—JUN—sarcoma	2.1e-05	0.00247	CbGpPWpGaD
Daunorubicin—Hypersensitivity—Vincristine—sarcoma	2.09e-05	0.000707	CcSEcCtD
Daunorubicin—ABCB1—lymphoid tissue—sarcoma	2.08e-05	0.0019	CbGeAlD
Daunorubicin—Dyspnoea—Etoposide—sarcoma	2.05e-05	0.000693	CcSEcCtD
Daunorubicin—Somnolence—Etoposide—sarcoma	2.04e-05	0.000691	CcSEcCtD
Daunorubicin—Angina pectoris—Doxorubicin—sarcoma	2.04e-05	0.000691	CcSEcCtD
Daunorubicin—Hypersensitivity—Mitoxantrone—sarcoma	2.04e-05	0.000688	CcSEcCtD
Daunorubicin—Asthenia—Vincristine—sarcoma	2.04e-05	0.000688	CcSEcCtD
Daunorubicin—Vomiting—Thiotepa—sarcoma	2.03e-05	0.000688	CcSEcCtD
Daunorubicin—Vomiting—Dactinomycin—sarcoma	2.02e-05	0.000683	CcSEcCtD
Daunorubicin—Rash—Thiotepa—sarcoma	2.02e-05	0.000682	CcSEcCtD
Daunorubicin—Dermatitis—Thiotepa—sarcoma	2.02e-05	0.000682	CcSEcCtD
Daunorubicin—Headache—Thiotepa—sarcoma	2e-05	0.000678	CcSEcCtD
Daunorubicin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—sarcoma	2e-05	0.00236	CbGpPWpGaD
Daunorubicin—Rash—Dactinomycin—sarcoma	2e-05	0.000677	CcSEcCtD
Daunorubicin—Decreased appetite—Etoposide—sarcoma	2e-05	0.000676	CcSEcCtD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	2e-05	0.00236	CbGpPWpGaD
Daunorubicin—Pancytopenia—Doxorubicin—sarcoma	1.99e-05	0.000673	CcSEcCtD
Daunorubicin—Renal failure—Epirubicin—sarcoma	1.99e-05	0.000672	CcSEcCtD
Daunorubicin—TOP2A—Idarubicin—Epirubicin—sarcoma	1.99e-05	0.0275	CbGdCrCtD
Daunorubicin—TOP2A—Doxorubicin—Epirubicin—sarcoma	1.99e-05	0.0275	CbGdCrCtD
Daunorubicin—Asthenia—Mitoxantrone—sarcoma	1.98e-05	0.00067	CcSEcCtD
Daunorubicin—Fatigue—Etoposide—sarcoma	1.98e-05	0.00067	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Epirubicin—sarcoma	1.98e-05	0.00067	CcSEcCtD
Daunorubicin—Stomatitis—Epirubicin—sarcoma	1.97e-05	0.000666	CcSEcCtD
Daunorubicin—Constipation—Etoposide—sarcoma	1.97e-05	0.000665	CcSEcCtD
Daunorubicin—Pain—Etoposide—sarcoma	1.97e-05	0.000665	CcSEcCtD
Daunorubicin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—sarcoma	1.97e-05	0.00232	CbGpPWpGaD
Daunorubicin—Conjunctivitis—Epirubicin—sarcoma	1.96e-05	0.000664	CcSEcCtD
Daunorubicin—YWHAG—mTOR signaling pathway—HRAS—sarcoma	1.96e-05	0.00231	CbGpPWpGaD
Daunorubicin—Neutropenia—Doxorubicin—sarcoma	1.96e-05	0.000663	CcSEcCtD
Daunorubicin—Dysuria—Doxorubicin—sarcoma	1.96e-05	0.000663	CcSEcCtD
Daunorubicin—Diarrhoea—Vincristine—sarcoma	1.94e-05	0.000657	CcSEcCtD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	1.94e-05	0.00229	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—STAG1—sarcoma	1.93e-05	0.00227	CbGpPWpGaD
Daunorubicin—YWHAG—ErbB1 downstream signaling—SRC—sarcoma	1.92e-05	0.00227	CbGpPWpGaD
Daunorubicin—Nausea—Thiotepa—sarcoma	1.9e-05	0.000643	CcSEcCtD
Daunorubicin—Sinusitis—Epirubicin—sarcoma	1.9e-05	0.000641	CcSEcCtD
Daunorubicin—Feeling abnormal—Etoposide—sarcoma	1.89e-05	0.000641	CcSEcCtD
Daunorubicin—ABCB1—bone marrow—sarcoma	1.89e-05	0.00173	CbGeAlD
Daunorubicin—Diarrhoea—Mitoxantrone—sarcoma	1.89e-05	0.000639	CcSEcCtD
Daunorubicin—Nausea—Dactinomycin—sarcoma	1.89e-05	0.000638	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Etoposide—sarcoma	1.88e-05	0.000636	CcSEcCtD
Daunorubicin—Dizziness—Vincristine—sarcoma	1.88e-05	0.000635	CcSEcCtD
Daunorubicin—YWHAG—PDGFR-beta signaling pathway—JUN—sarcoma	1.86e-05	0.0022	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—CXCR4—sarcoma	1.86e-05	0.00219	CbGpPWpGaD
Daunorubicin—YWHAG—ErbB1 downstream signaling—NRAS—sarcoma	1.85e-05	0.00218	CbGpPWpGaD
Daunorubicin—ABCG2—HIF-1-alpha transcription factor network—CREB1—sarcoma	1.84e-05	0.00217	CbGpPWpGaD
Daunorubicin—Renal failure—Doxorubicin—sarcoma	1.84e-05	0.000621	CcSEcCtD
Daunorubicin—TOP2A—Idarubicin—Doxorubicin—sarcoma	1.84e-05	0.0254	CbGdCrCtD
Daunorubicin—TOP2A—Epirubicin—Doxorubicin—sarcoma	1.84e-05	0.0254	CbGdCrCtD
Daunorubicin—Neuropathy peripheral—Doxorubicin—sarcoma	1.83e-05	0.00062	CcSEcCtD
Daunorubicin—Urticaria—Etoposide—sarcoma	1.83e-05	0.000617	CcSEcCtD
Daunorubicin—Stomatitis—Doxorubicin—sarcoma	1.82e-05	0.000616	CcSEcCtD
Daunorubicin—Rhinitis—Epirubicin—sarcoma	1.82e-05	0.000615	CcSEcCtD
Daunorubicin—Abdominal pain—Etoposide—sarcoma	1.82e-05	0.000614	CcSEcCtD
Daunorubicin—Body temperature increased—Etoposide—sarcoma	1.82e-05	0.000614	CcSEcCtD
Daunorubicin—Conjunctivitis—Doxorubicin—sarcoma	1.82e-05	0.000614	CcSEcCtD
Daunorubicin—Vomiting—Vincristine—sarcoma	1.8e-05	0.00061	CcSEcCtD
Daunorubicin—Rash—Vincristine—sarcoma	1.79e-05	0.000605	CcSEcCtD
Daunorubicin—Dermatitis—Vincristine—sarcoma	1.79e-05	0.000604	CcSEcCtD
Daunorubicin—Headache—Vincristine—sarcoma	1.78e-05	0.000601	CcSEcCtD
Daunorubicin—NR5A1—Developmental Biology—KDR—sarcoma	1.76e-05	0.00208	CbGpPWpGaD
Daunorubicin—Vomiting—Mitoxantrone—sarcoma	1.76e-05	0.000594	CcSEcCtD
Daunorubicin—Sinusitis—Doxorubicin—sarcoma	1.75e-05	0.000593	CcSEcCtD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	1.75e-05	0.00206	CbGpPWpGaD
Daunorubicin—Visual impairment—Epirubicin—sarcoma	1.75e-05	0.000591	CcSEcCtD
Daunorubicin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—sarcoma	1.75e-05	0.00206	CbGpPWpGaD
Daunorubicin—Rash—Mitoxantrone—sarcoma	1.74e-05	0.000589	CcSEcCtD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—SRC—sarcoma	1.74e-05	0.00206	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	1.74e-05	0.00206	CbGpPWpGaD
Daunorubicin—Dermatitis—Mitoxantrone—sarcoma	1.74e-05	0.000589	CcSEcCtD
Daunorubicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	1.74e-05	0.00205	CbGpPWpGaD
Daunorubicin—Headache—Mitoxantrone—sarcoma	1.73e-05	0.000585	CcSEcCtD
Daunorubicin—TOP2A—Cell Cycle—STAG1—sarcoma	1.72e-05	0.00203	CbGpPWpGaD
Daunorubicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	1.71e-05	0.00202	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	1.7e-05	0.002	CbGpPWpGaD
Daunorubicin—Hypersensitivity—Etoposide—sarcoma	1.69e-05	0.000573	CcSEcCtD
Daunorubicin—Tinnitus—Epirubicin—sarcoma	1.69e-05	0.000572	CcSEcCtD
Daunorubicin—Nausea—Vincristine—sarcoma	1.69e-05	0.00057	CcSEcCtD
Daunorubicin—YWHAG—ErbB1 downstream signaling—EGFR—sarcoma	1.68e-05	0.00199	CbGpPWpGaD
Daunorubicin—Cardiac disorder—Epirubicin—sarcoma	1.68e-05	0.000569	CcSEcCtD
Daunorubicin—Flushing—Epirubicin—sarcoma	1.68e-05	0.000569	CcSEcCtD
Daunorubicin—Rhinitis—Doxorubicin—sarcoma	1.68e-05	0.000569	CcSEcCtD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—NRAS—sarcoma	1.68e-05	0.00198	CbGpPWpGaD
Daunorubicin—YWHAG—PDGFR-beta signaling pathway—SRC—sarcoma	1.67e-05	0.00197	CbGpPWpGaD
Daunorubicin—Asthenia—Etoposide—sarcoma	1.65e-05	0.000558	CcSEcCtD
Daunorubicin—Nausea—Mitoxantrone—sarcoma	1.64e-05	0.000555	CcSEcCtD
Daunorubicin—Chills—Epirubicin—sarcoma	1.63e-05	0.00055	CcSEcCtD
Daunorubicin—Pruritus—Etoposide—sarcoma	1.63e-05	0.00055	CcSEcCtD
Daunorubicin—Arrhythmia—Epirubicin—sarcoma	1.62e-05	0.000548	CcSEcCtD
Daunorubicin—ABCB1—testis—sarcoma	1.62e-05	0.00148	CbGeAlD
Daunorubicin—Visual impairment—Doxorubicin—sarcoma	1.62e-05	0.000547	CcSEcCtD
Daunorubicin—YWHAG—PDGFR-beta signaling pathway—NRAS—sarcoma	1.61e-05	0.0019	CbGpPWpGaD
Daunorubicin—Alopecia—Epirubicin—sarcoma	1.6e-05	0.000542	CcSEcCtD
Daunorubicin—YWHAG—ErbB1 downstream signaling—KRAS—sarcoma	1.59e-05	0.00188	CbGpPWpGaD
Daunorubicin—Erythema—Epirubicin—sarcoma	1.58e-05	0.000534	CcSEcCtD
Daunorubicin—Diarrhoea—Etoposide—sarcoma	1.57e-05	0.000532	CcSEcCtD
Daunorubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—JUN—sarcoma	1.57e-05	0.00185	CbGpPWpGaD
Daunorubicin—Tinnitus—Doxorubicin—sarcoma	1.56e-05	0.000529	CcSEcCtD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—JUN—sarcoma	1.56e-05	0.00184	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—MYC—sarcoma	1.56e-05	0.00184	CbGpPWpGaD
Daunorubicin—Cardiac disorder—Doxorubicin—sarcoma	1.56e-05	0.000527	CcSEcCtD
Daunorubicin—Flushing—Doxorubicin—sarcoma	1.56e-05	0.000527	CcSEcCtD
Daunorubicin—YWHAG—Apoptosis—CTNNB1—sarcoma	1.56e-05	0.00184	CbGpPWpGaD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—CTNNB1—sarcoma	1.55e-05	0.00183	CbGpPWpGaD
Daunorubicin—Dysgeusia—Epirubicin—sarcoma	1.55e-05	0.000523	CcSEcCtD
Daunorubicin—NR5A1—Developmental Biology—CREB1—sarcoma	1.55e-05	0.00182	CbGpPWpGaD
Daunorubicin—ABCB1—liver—sarcoma	1.53e-05	0.00139	CbGeAlD
Daunorubicin—Back pain—Epirubicin—sarcoma	1.53e-05	0.000516	CcSEcCtD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	1.53e-05	0.0018	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	1.53e-05	0.0018	CbGpPWpGaD
Daunorubicin—ABCG2—Fluoropyrimidine Activity—TP53—sarcoma	1.52e-05	0.00179	CbGpPWpGaD
Daunorubicin—Dizziness—Etoposide—sarcoma	1.52e-05	0.000514	CcSEcCtD
Daunorubicin—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	1.51e-05	0.00178	CbGpPWpGaD
Daunorubicin—Chills—Doxorubicin—sarcoma	1.51e-05	0.000509	CcSEcCtD
Daunorubicin—Arrhythmia—Doxorubicin—sarcoma	1.5e-05	0.000507	CcSEcCtD
Daunorubicin—YWHAG—PDGFR-beta signaling pathway—MYC—sarcoma	1.5e-05	0.00177	CbGpPWpGaD
Daunorubicin—Alopecia—Doxorubicin—sarcoma	1.48e-05	0.000501	CcSEcCtD
Daunorubicin—TOP2A—Cell Cycle—NPM1—sarcoma	1.48e-05	0.00174	CbGpPWpGaD
Daunorubicin—Ill-defined disorder—Epirubicin—sarcoma	1.47e-05	0.000495	CcSEcCtD
Daunorubicin—Vomiting—Etoposide—sarcoma	1.46e-05	0.000494	CcSEcCtD
Daunorubicin—Erythema—Doxorubicin—sarcoma	1.46e-05	0.000494	CcSEcCtD
Daunorubicin—Anaemia—Epirubicin—sarcoma	1.46e-05	0.000493	CcSEcCtD
Daunorubicin—Agitation—Epirubicin—sarcoma	1.45e-05	0.000491	CcSEcCtD
Daunorubicin—Rash—Etoposide—sarcoma	1.45e-05	0.00049	CcSEcCtD
Daunorubicin—Dermatitis—Etoposide—sarcoma	1.45e-05	0.00049	CcSEcCtD
Daunorubicin—YWHAG—Cell Cycle—TP53—sarcoma	1.45e-05	0.00171	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	1.44e-05	0.0017	CbGpPWpGaD
Daunorubicin—Headache—Etoposide—sarcoma	1.44e-05	0.000487	CcSEcCtD
Daunorubicin—NR5A1—Developmental Biology—MMP2—sarcoma	1.44e-05	0.0017	CbGpPWpGaD
Daunorubicin—Dysgeusia—Doxorubicin—sarcoma	1.43e-05	0.000484	CcSEcCtD
Daunorubicin—Malaise—Epirubicin—sarcoma	1.42e-05	0.000481	CcSEcCtD
Daunorubicin—Syncope—Epirubicin—sarcoma	1.42e-05	0.000479	CcSEcCtD
Daunorubicin—Leukopenia—Epirubicin—sarcoma	1.41e-05	0.000478	CcSEcCtD
Daunorubicin—Back pain—Doxorubicin—sarcoma	1.41e-05	0.000478	CcSEcCtD
Daunorubicin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—sarcoma	1.4e-05	0.00165	CbGpPWpGaD
Daunorubicin—Palpitations—Epirubicin—sarcoma	1.4e-05	0.000472	CcSEcCtD
Daunorubicin—Loss of consciousness—Epirubicin—sarcoma	1.39e-05	0.000469	CcSEcCtD
Daunorubicin—YWHAG—PDGFR-beta signaling pathway—KRAS—sarcoma	1.38e-05	0.00163	CbGpPWpGaD
Daunorubicin—Cough—Epirubicin—sarcoma	1.38e-05	0.000466	CcSEcCtD
Daunorubicin—CYP1A1—Tryptophan metabolism—MDM2—sarcoma	1.38e-05	0.00162	CbGpPWpGaD
Daunorubicin—Convulsion—Epirubicin—sarcoma	1.37e-05	0.000463	CcSEcCtD
Daunorubicin—Nausea—Etoposide—sarcoma	1.37e-05	0.000462	CcSEcCtD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—VEGFA—sarcoma	1.36e-05	0.00161	CbGpPWpGaD
Daunorubicin—Hypertension—Epirubicin—sarcoma	1.36e-05	0.000461	CcSEcCtD
Daunorubicin—Ill-defined disorder—Doxorubicin—sarcoma	1.36e-05	0.000458	CcSEcCtD
Daunorubicin—YWHAG—ErbB1 downstream signaling—HRAS—sarcoma	1.35e-05	0.0016	CbGpPWpGaD
Daunorubicin—Anaemia—Doxorubicin—sarcoma	1.35e-05	0.000457	CcSEcCtD
Daunorubicin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	1.35e-05	0.00159	CbGpPWpGaD
Daunorubicin—Chest pain—Epirubicin—sarcoma	1.34e-05	0.000455	CcSEcCtD
Daunorubicin—Myalgia—Epirubicin—sarcoma	1.34e-05	0.000455	CcSEcCtD
Daunorubicin—Arthralgia—Epirubicin—sarcoma	1.34e-05	0.000455	CcSEcCtD
Daunorubicin—Agitation—Doxorubicin—sarcoma	1.34e-05	0.000454	CcSEcCtD
Daunorubicin—Anxiety—Epirubicin—sarcoma	1.34e-05	0.000453	CcSEcCtD
Daunorubicin—Discomfort—Epirubicin—sarcoma	1.33e-05	0.000449	CcSEcCtD
Daunorubicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	1.33e-05	0.00157	CbGpPWpGaD
Daunorubicin—ABCG2—HIF-1-alpha transcription factor network—JUN—sarcoma	1.32e-05	0.00156	CbGpPWpGaD
Daunorubicin—Malaise—Doxorubicin—sarcoma	1.32e-05	0.000445	CcSEcCtD
Daunorubicin—Dry mouth—Epirubicin—sarcoma	1.31e-05	0.000445	CcSEcCtD
Daunorubicin—Syncope—Doxorubicin—sarcoma	1.31e-05	0.000443	CcSEcCtD
Daunorubicin—Leukopenia—Doxorubicin—sarcoma	1.31e-05	0.000442	CcSEcCtD
Daunorubicin—Confusional state—Epirubicin—sarcoma	1.3e-05	0.000439	CcSEcCtD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	1.29e-05	0.00152	CbGpPWpGaD
Daunorubicin—Palpitations—Doxorubicin—sarcoma	1.29e-05	0.000437	CcSEcCtD
Daunorubicin—Anaphylactic shock—Epirubicin—sarcoma	1.29e-05	0.000436	CcSEcCtD
Daunorubicin—Oedema—Epirubicin—sarcoma	1.29e-05	0.000436	CcSEcCtD
Daunorubicin—Loss of consciousness—Doxorubicin—sarcoma	1.28e-05	0.000434	CcSEcCtD
Daunorubicin—Infection—Epirubicin—sarcoma	1.28e-05	0.000433	CcSEcCtD
Daunorubicin—Cough—Doxorubicin—sarcoma	1.27e-05	0.000431	CcSEcCtD
Daunorubicin—Shock—Epirubicin—sarcoma	1.27e-05	0.000429	CcSEcCtD
Daunorubicin—Convulsion—Doxorubicin—sarcoma	1.27e-05	0.000428	CcSEcCtD
Daunorubicin—Thrombocytopenia—Epirubicin—sarcoma	1.26e-05	0.000427	CcSEcCtD
Daunorubicin—Hypertension—Doxorubicin—sarcoma	1.26e-05	0.000426	CcSEcCtD
Daunorubicin—Tachycardia—Epirubicin—sarcoma	1.26e-05	0.000425	CcSEcCtD
Daunorubicin—Hyperhidrosis—Epirubicin—sarcoma	1.25e-05	0.000421	CcSEcCtD
Daunorubicin—Arthralgia—Doxorubicin—sarcoma	1.24e-05	0.000421	CcSEcCtD
Daunorubicin—Chest pain—Doxorubicin—sarcoma	1.24e-05	0.000421	CcSEcCtD
Daunorubicin—Myalgia—Doxorubicin—sarcoma	1.24e-05	0.000421	CcSEcCtD
Daunorubicin—TOP2A—Circadian rythm related genes—CREB1—sarcoma	1.24e-05	0.00146	CbGpPWpGaD
Daunorubicin—Anxiety—Doxorubicin—sarcoma	1.24e-05	0.000419	CcSEcCtD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	1.23e-05	0.00145	CbGpPWpGaD
Daunorubicin—Discomfort—Doxorubicin—sarcoma	1.23e-05	0.000416	CcSEcCtD
Daunorubicin—TOP2A—Mitotic G1-G1/S phases—CCND1—sarcoma	1.23e-05	0.00145	CbGpPWpGaD
Daunorubicin—Anorexia—Epirubicin—sarcoma	1.23e-05	0.000415	CcSEcCtD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	1.23e-05	0.00145	CbGpPWpGaD
Daunorubicin—Dry mouth—Doxorubicin—sarcoma	1.22e-05	0.000411	CcSEcCtD
Daunorubicin—Confusional state—Doxorubicin—sarcoma	1.2e-05	0.000406	CcSEcCtD
Daunorubicin—YWHAG—Membrane Trafficking—SRC—sarcoma	1.2e-05	0.00141	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	1.2e-05	0.00141	CbGpPWpGaD
Daunorubicin—Anaphylactic shock—Doxorubicin—sarcoma	1.19e-05	0.000403	CcSEcCtD
Daunorubicin—Oedema—Doxorubicin—sarcoma	1.19e-05	0.000403	CcSEcCtD
Daunorubicin—Infection—Doxorubicin—sarcoma	1.18e-05	0.000401	CcSEcCtD
Daunorubicin—YWHAG—PDGFR-beta signaling pathway—HRAS—sarcoma	1.18e-05	0.00139	CbGpPWpGaD
Daunorubicin—Musculoskeletal discomfort—Epirubicin—sarcoma	1.17e-05	0.000397	CcSEcCtD
Daunorubicin—ABCB1—lymph node—sarcoma	1.17e-05	0.00107	CbGeAlD
Daunorubicin—Shock—Doxorubicin—sarcoma	1.17e-05	0.000397	CcSEcCtD
Daunorubicin—Thrombocytopenia—Doxorubicin—sarcoma	1.17e-05	0.000395	CcSEcCtD
Daunorubicin—ABCB1—Allograft Rejection—PDGFRA—sarcoma	1.17e-05	0.00138	CbGpPWpGaD
Daunorubicin—Insomnia—Epirubicin—sarcoma	1.17e-05	0.000394	CcSEcCtD
Daunorubicin—Tachycardia—Doxorubicin—sarcoma	1.16e-05	0.000393	CcSEcCtD
Daunorubicin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—sarcoma	1.16e-05	0.00136	CbGpPWpGaD
Daunorubicin—Hyperhidrosis—Doxorubicin—sarcoma	1.15e-05	0.00039	CcSEcCtD
Daunorubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—sarcoma	1.15e-05	0.00136	CbGpPWpGaD
Daunorubicin—Dyspnoea—Epirubicin—sarcoma	1.15e-05	0.000388	CcSEcCtD
Daunorubicin—Somnolence—Epirubicin—sarcoma	1.15e-05	0.000387	CcSEcCtD
Daunorubicin—Anorexia—Doxorubicin—sarcoma	1.14e-05	0.000384	CcSEcCtD
Daunorubicin—Decreased appetite—Epirubicin—sarcoma	1.12e-05	0.000379	CcSEcCtD
Daunorubicin—Fatigue—Epirubicin—sarcoma	1.11e-05	0.000376	CcSEcCtD
Daunorubicin—NR5A1—Developmental Biology—CTNNB1—sarcoma	1.1e-05	0.0013	CbGpPWpGaD
Daunorubicin—Pain—Epirubicin—sarcoma	1.1e-05	0.000373	CcSEcCtD
Daunorubicin—Constipation—Epirubicin—sarcoma	1.1e-05	0.000373	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Doxorubicin—sarcoma	1.09e-05	0.000367	CcSEcCtD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	1.09e-05	0.00128	CbGpPWpGaD
Daunorubicin—Insomnia—Doxorubicin—sarcoma	1.08e-05	0.000365	CcSEcCtD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—SRC—sarcoma	1.07e-05	0.00127	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	1.07e-05	0.00127	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	1.07e-05	0.00126	CbGpPWpGaD
Daunorubicin—Dyspnoea—Doxorubicin—sarcoma	1.06e-05	0.000359	CcSEcCtD
Daunorubicin—Feeling abnormal—Epirubicin—sarcoma	1.06e-05	0.000359	CcSEcCtD
Daunorubicin—Somnolence—Doxorubicin—sarcoma	1.06e-05	0.000358	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Epirubicin—sarcoma	1.05e-05	0.000356	CcSEcCtD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	1.04e-05	0.00123	CbGpPWpGaD
Daunorubicin—Decreased appetite—Doxorubicin—sarcoma	1.04e-05	0.00035	CcSEcCtD
Daunorubicin—YWHAG—Apoptosis—TP53—sarcoma	1.04e-05	0.00122	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—sarcoma	1.03e-05	0.00122	CbGpPWpGaD
Daunorubicin—Fatigue—Doxorubicin—sarcoma	1.03e-05	0.000348	CcSEcCtD
Daunorubicin—Urticaria—Epirubicin—sarcoma	1.02e-05	0.000346	CcSEcCtD
Daunorubicin—Constipation—Doxorubicin—sarcoma	1.02e-05	0.000345	CcSEcCtD
Daunorubicin—Pain—Doxorubicin—sarcoma	1.02e-05	0.000345	CcSEcCtD
Daunorubicin—Abdominal pain—Epirubicin—sarcoma	1.02e-05	0.000344	CcSEcCtD
Daunorubicin—Body temperature increased—Epirubicin—sarcoma	1.02e-05	0.000344	CcSEcCtD
Daunorubicin—NR5A1—Developmental Biology—SRC—sarcoma	9.97e-06	0.00118	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	9.95e-06	0.00117	CbGpPWpGaD
Daunorubicin—TOP2A—Mitotic G1-G1/S phases—MYC—sarcoma	9.85e-06	0.00116	CbGpPWpGaD
Daunorubicin—Feeling abnormal—Doxorubicin—sarcoma	9.83e-06	0.000332	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Doxorubicin—sarcoma	9.75e-06	0.00033	CcSEcCtD
Daunorubicin—NR5A1—Developmental Biology—VEGFA—sarcoma	9.71e-06	0.00115	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—sarcoma	9.61e-06	0.00113	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—NRAS—sarcoma	9.59e-06	0.00113	CbGpPWpGaD
Daunorubicin—Hypersensitivity—Epirubicin—sarcoma	9.49e-06	0.000321	CcSEcCtD
Daunorubicin—NR5A1—Generic Transcription Pathway—MYC—sarcoma	9.49e-06	0.00112	CbGpPWpGaD
Daunorubicin—Urticaria—Doxorubicin—sarcoma	9.47e-06	0.00032	CcSEcCtD
Daunorubicin—Body temperature increased—Doxorubicin—sarcoma	9.43e-06	0.000319	CcSEcCtD
Daunorubicin—Abdominal pain—Doxorubicin—sarcoma	9.43e-06	0.000319	CcSEcCtD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	9.4e-06	0.00111	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	9.4e-06	0.00111	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	9.31e-06	0.0011	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	9.29e-06	0.0011	CbGpPWpGaD
Daunorubicin—Asthenia—Epirubicin—sarcoma	9.25e-06	0.000313	CcSEcCtD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	9.22e-06	0.00109	CbGpPWpGaD
Daunorubicin—Pruritus—Epirubicin—sarcoma	9.12e-06	0.000308	CcSEcCtD
Daunorubicin—TOP2A—Circadian rythm related genes—JUN—sarcoma	8.92e-06	0.00105	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	8.88e-06	0.00105	CbGpPWpGaD
Daunorubicin—Diarrhoea—Epirubicin—sarcoma	8.82e-06	0.000298	CcSEcCtD
Daunorubicin—Hypersensitivity—Doxorubicin—sarcoma	8.78e-06	0.000297	CcSEcCtD
Daunorubicin—CYP1A2—Tryptophan metabolism—MDM2—sarcoma	8.77e-06	0.00104	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—EGFR—sarcoma	8.74e-06	0.00103	CbGpPWpGaD
Daunorubicin—Asthenia—Doxorubicin—sarcoma	8.55e-06	0.000289	CcSEcCtD
Daunorubicin—Dizziness—Epirubicin—sarcoma	8.52e-06	0.000288	CcSEcCtD
Daunorubicin—Pruritus—Doxorubicin—sarcoma	8.44e-06	0.000285	CcSEcCtD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	8.33e-06	0.000983	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—KRAS—sarcoma	8.25e-06	0.000974	CbGpPWpGaD
Daunorubicin—Vomiting—Epirubicin—sarcoma	8.19e-06	0.000277	CcSEcCtD
Daunorubicin—Diarrhoea—Doxorubicin—sarcoma	8.16e-06	0.000276	CcSEcCtD
Daunorubicin—Rash—Epirubicin—sarcoma	8.13e-06	0.000275	CcSEcCtD
Daunorubicin—Dermatitis—Epirubicin—sarcoma	8.12e-06	0.000274	CcSEcCtD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	8.11e-06	0.000957	CbGpPWpGaD
Daunorubicin—Headache—Epirubicin—sarcoma	8.07e-06	0.000273	CcSEcCtD
Daunorubicin—Dizziness—Doxorubicin—sarcoma	7.88e-06	0.000267	CcSEcCtD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	7.84e-06	0.000925	CbGpPWpGaD
Daunorubicin—Nausea—Epirubicin—sarcoma	7.65e-06	0.000259	CcSEcCtD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	7.62e-06	0.0009	CbGpPWpGaD
Daunorubicin—Vomiting—Doxorubicin—sarcoma	7.58e-06	0.000256	CcSEcCtD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	7.55e-06	0.000891	CbGpPWpGaD
Daunorubicin—Rash—Doxorubicin—sarcoma	7.52e-06	0.000254	CcSEcCtD
Daunorubicin—Dermatitis—Doxorubicin—sarcoma	7.51e-06	0.000254	CcSEcCtD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—CREB1—sarcoma	7.5e-06	0.000885	CbGpPWpGaD
Daunorubicin—Headache—Doxorubicin—sarcoma	7.47e-06	0.000253	CcSEcCtD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	7.46e-06	0.000881	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	7.3e-06	0.000862	CbGpPWpGaD
Daunorubicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	7.3e-06	0.000861	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	7.15e-06	0.000844	CbGpPWpGaD
Daunorubicin—Nausea—Doxorubicin—sarcoma	7.08e-06	0.000239	CcSEcCtD
Daunorubicin—NR5A1—Developmental Biology—HRAS—sarcoma	7.01e-06	0.000828	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	6.9e-06	0.000814	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—ENO2—sarcoma	6.87e-06	0.000811	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	6.84e-06	0.000807	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—sarcoma	6.84e-06	0.000807	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—HBA1—sarcoma	6.83e-06	0.000806	CbGpPWpGaD
Daunorubicin—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	6.77e-06	0.000799	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	6.66e-06	0.000786	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—MDM2—sarcoma	6.61e-06	0.00078	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	6.58e-06	0.000776	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—CCND1—sarcoma	6.44e-06	0.00076	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—IL2—sarcoma	6.37e-06	0.000752	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	6.25e-06	0.000738	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—MDM2—sarcoma	6.21e-06	0.000732	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	6.13e-06	0.000723	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—sarcoma	6.13e-06	0.000723	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	5.99e-06	0.000707	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	5.99e-06	0.000707	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—TP53—sarcoma	5.88e-06	0.000694	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PLCG1—sarcoma	5.83e-06	0.000688	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TLE1—sarcoma	5.82e-06	0.000686	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	5.76e-06	0.00068	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—CCND1—sarcoma	5.76e-06	0.00068	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—CREB1—sarcoma	5.75e-06	0.000678	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	5.66e-06	0.000668	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—VEGFA—sarcoma	5.41e-06	0.000639	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NPM1—sarcoma	5.25e-06	0.000619	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—MYC—sarcoma	5.17e-06	0.00061	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—ENO2—sarcoma	5.07e-06	0.000598	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—HBA1—sarcoma	5.04e-06	0.000594	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	4.81e-06	0.000568	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—MDM2—sarcoma	4.76e-06	0.000561	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—MDM2—sarcoma	4.62e-06	0.000546	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—MYC—sarcoma	4.62e-06	0.000545	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—MYC—sarcoma	4.57e-06	0.000539	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—ENO2—sarcoma	4.55e-06	0.000536	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CCND1—sarcoma	4.51e-06	0.000532	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PLCG1—sarcoma	4.3e-06	0.000507	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	4.25e-06	0.000502	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CCND1—sarcoma	4.03e-06	0.000475	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PLCG1—sarcoma	3.86e-06	0.000455	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ENO2—sarcoma	3.81e-06	0.000449	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—TP53—sarcoma	3.79e-06	0.000448	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—HBA1—sarcoma	3.78e-06	0.000446	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CXCR4—sarcoma	3.71e-06	0.000437	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ENO2—sarcoma	3.68e-06	0.000434	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—HBA1—sarcoma	3.66e-06	0.000432	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—MYC—sarcoma	3.61e-06	0.000426	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	3.52e-06	0.000415	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—HRAS—sarcoma	3.41e-06	0.000402	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ENO2—sarcoma	3.35e-06	0.000395	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—HBA1—sarcoma	3.33e-06	0.000393	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ENO2—sarcoma	3.31e-06	0.000391	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—HBA1—sarcoma	3.29e-06	0.000389	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—MYC—sarcoma	3.23e-06	0.000381	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PLCG1—sarcoma	3.23e-06	0.000381	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PLCG1—sarcoma	3.12e-06	0.000369	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	3.06e-06	0.000362	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	3.06e-06	0.000361	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	3.03e-06	0.000358	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PLCG1—sarcoma	2.84e-06	0.000335	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PLCG1—sarcoma	2.81e-06	0.000332	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	2.74e-06	0.000324	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—FOXO1—sarcoma	2.74e-06	0.000323	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PDGFRB—sarcoma	2.73e-06	0.000322	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PDGFRA—sarcoma	2.69e-06	0.000317	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	2.67e-06	0.000315	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TP53—sarcoma	2.65e-06	0.000313	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—HRAS—sarcoma	2.61e-06	0.000308	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	2.46e-06	0.00029	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	2.4e-06	0.000284	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ENO2—sarcoma	2.4e-06	0.000283	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—HBA1—sarcoma	2.38e-06	0.000281	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	2.27e-06	0.000268	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ENO2—sarcoma	2.27e-06	0.000268	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—HBA1—sarcoma	2.25e-06	0.000266	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—KIT—sarcoma	2.08e-06	0.000246	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PLCG1—sarcoma	2.04e-06	0.00024	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	2.02e-06	0.000238	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CREB1—sarcoma	1.98e-06	0.000234	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PLCG1—sarcoma	1.92e-06	0.000227	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ENO2—sarcoma	1.81e-06	0.000214	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—HBA1—sarcoma	1.8e-06	0.000212	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MDM2—sarcoma	1.64e-06	0.000194	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PLCG1—sarcoma	1.54e-06	0.000181	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ENO2—sarcoma	1.45e-06	0.000171	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—HBA1—sarcoma	1.44e-06	0.00017	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CTNNB1—sarcoma	1.42e-06	0.000167	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SRC—sarcoma	1.28e-06	0.000151	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NRAS—sarcoma	1.23e-06	0.000145	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PLCG1—sarcoma	1.23e-06	0.000145	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MYC—sarcoma	1.15e-06	0.000135	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—EGFR—sarcoma	1.12e-06	0.000132	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ENO2—sarcoma	1.12e-06	0.000132	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HBA1—sarcoma	1.11e-06	0.000131	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—KRAS—sarcoma	1.06e-06	0.000125	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PLCG1—sarcoma	9.47e-07	0.000112	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HRAS—sarcoma	9.01e-07	0.000106	CbGpPWpGaD
